Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 16, 2016

Total Value: $246M (100.0% shares, 0.0% debt)

Holdings (22)

— Medivation, Inc. 82.1%

Value $202M Shares 4,397,838 Est. Cost $45.85 Unrealized —

— Synthetic Biologics Inc. 3.6%

Value $8.813M Shares 3,734,149 Est. Cost $1.55 Unrealized —

— Ampio Pharmaceuticals Inc. 3.1%

Value $7.624M Shares 3,388,322 Est. Cost $6.03 Unrealized —

— Corbus Pharmaceuticals HLDGS 1.9%

Value $4.641M Shares 2,563,925 Est. Cost $2.53 Unrealized —

— Alcobra Ltd 1.7%

Value $4.227M Shares 1,115,315 Est. Cost $7.08 Unrealized —

— Abeona Therapeutics Inc 1.4%

Value $3.481M Shares 1,359,767 Est. Cost $5.06 Unrealized —

— Cempra Inc 1.3%

Value $3.168M Shares 180,800 Est. Cost $31.13 Unrealized —

— Advaxis Inc. 1.0%

Value $2.483M Shares 275,000 Est. Cost $9.03 Unrealized —

— Newlink Genetics Corp 0.8%

Value $1.864M Shares 102,437 Est. Cost $27.98 Unrealized —

VNRX Volition RX LTD 0.7%

Value $1.638M Shares 461,538 Est. Cost $3.75 Unrealized 0.0%

— Vascular Biologics LTD 0.5%

Value $1.16M Shares 333,332 Est. Cost $5.26 Unrealized —

— Keryx Biopharmaceuticals Inc. 0.4%

Value $934K Shares 200,000 Est. Cost $10.21 Unrealized —

— Advaxis Inc. 0.3%

Value $677K Shares 112,500 Est. Cost $6.02 Unrealized —

— OHR Pharmaceutical Inc 0.3%

Value $658K Shares 205,000 Est. Cost $2.54 Unrealized —

— Bio Blast Pharma Ltd 0.3%

Value $625K Shares 250,970 Est. Cost $7.27 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.2%

Value $569K Shares 135,800 Est. Cost $10.20 Unrealized -52.9%

— Caladrius Biosciences Inc 0.2%

Value $417K Shares 555,781 Est. Cost $1.87 Unrealized —

CSBR Champions Oncology INC 0.2%

Value $405K Shares 111,111 Est. Cost $4.66 Unrealized -21.3%

— Galmed Pharmaceuticals Ltd 0.1%

Value $320K Shares 65,000 Est. Cost $11.48 Unrealized —

— Evoke Pharma Inc 0.1%

Value $283K Shares 55,660 Est. Cost $7.00 Unrealized —

— Zosano Pharma Corp 0.0%

Value $43,000 Shares 18,600 Est. Cost $10.10 Unrealized —

— Aptose Biosciences Inc 0.0%

Value $34,000 Shares 11,933 Est. Cost $5.40 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	4,397,838	$202M	82.1%	$45.85	—	COM	58501N101
—	Synthetic Biologics Inc.	3,734,149	$8.813M	3.6%	$1.55	—	COM	87164U102
—	Ampio Pharmaceuticals Inc.	3,388,322	$7.624M	3.1%	$6.03	—	COM	03209T109
—	Corbus Pharmaceuticals HLDGS	2,563,925	$4.641M	1.9%	$2.53	—	COM	21833P103
—	Alcobra Ltd	1,115,315	$4.227M	1.7%	$7.08	—	SHS	M2239P109
—	Abeona Therapeutics Inc	1,359,767	$3.481M	1.4%	$5.06	—	COM	00289Y107
—	Cempra Inc	180,800	$3.168M	1.3%	$31.13	—	COM	15130J109
—	Advaxis Inc.	275,000	$2.483M	1.0%	$9.03	—	COM NEW	7624208
—	Newlink Genetics Corp	102,437	$1.864M	0.8%	$27.98	—	COM	651511107
VNRX	Volition RX LTD	461,538	$1.638M	0.7%	$3.75	0.0%	COM	928661107
—	Vascular Biologics LTD	333,332	$1.16M	0.5%	$5.26	—	COM	96883109
—	Keryx Biopharmaceuticals Inc.	200,000	$934K	0.4%	$10.21	—	COM	492515101
—	Advaxis Inc.	112,500	$677K	0.3%	$6.02	—	W EXP 07/15/201	7624117
—	OHR Pharmaceutical Inc	205,000	$658K	0.3%	$2.54	—	COM NEW	67778H200
—	Bio Blast Pharma Ltd	250,970	$625K	0.3%	$7.27	—	SHS	M20156101
ALDX	Aldeyra Therapeutics Inc	135,800	$569K	0.2%	$10.20	-52.9%	COM	01438T106
—	Caladrius Biosciences Inc	555,781	$417K	0.2%	$1.87	—	COM	128058104
CSBR	Champions Oncology INC	111,111	$405K	0.2%	$4.66	-21.3%	COMM NEW	15870P307
—	Galmed Pharmaceuticals Ltd	65,000	$320K	0.1%	$11.48	—	SHS	M47238106
—	Evoke Pharma Inc	55,660	$283K	0.1%	$7.00	—	COM	30049G104
—	Zosano Pharma Corp	18,600	$43,000	0.0%	$10.10	—	COM	98979H103
—	Aptose Biosciences Inc	11,933	$34,000	0.0%	$5.40	—	COM NEW	03835T200